Stereotactic Surgery Devices

Stereotactic Surgery Devices

Global Stereotactic Surgery Devices Market to Reach US$31.0 Billion by 2030

The global market for Stereotactic Surgery Devices estimated at US$21.3 Billion in the year 2023, is expected to reach US$31.0 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Linear Accelerator (LINAC), one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$23.2 Billion by the end of the analysis period. Growth in the Proton Beam Radiotherapy segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.6 Billion While China is Forecast to Grow at 8.5% CAGR

The Stereotactic Surgery Devices market in the U.S. is estimated at US$5.6 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.0 Billion by the year 2030 trailing a CAGR of 8.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Stereotactic Surgery Devices Market - Key Trends and Drivers Summarized

How Are Stereotactic Surgery Devices Improving Precision in Neurosurgery?

Stereotactic surgery devices are advanced medical tools used to perform minimally invasive procedures in the brain, spine, and other parts of the body with high precision. These devices use a 3D coordinate system to locate specific targets within the body, enabling accurate biopsies, tumor removal, and implantation of electrodes for neurological treatments. Stereotactic surgery combines imaging techniques such as MRI, CT, and PET scans with specialized equipment like stereotactic frames, navigation systems, and probes, allowing surgeons to operate on critical structures without damaging surrounding tissues. As neurosurgical procedures become more complex, the adoption of stereotactic surgery devices has increased, supporting safer and more effective interventions.

What Are the Key Segments in the Stereotactic Surgery Devices Market?

Key product types include stereotactic frames, image-guided navigation systems, robotic systems, and instruments like electrodes and biopsy needles, with image-guided navigation systems holding the largest market share due to their ability to provide real-time visualization and guidance during surgery. Applications cover neurosurgery, brain tumor treatment, epilepsy surgery, biopsies, and radiation therapy, with neurosurgery representing a significant segment driven by the need for precise interventions in conditions like Parkinson’s disease, epilepsy, and brain tumors. End-users include hospitals, specialty clinics, and research institutes, with hospitals leading the market as they provide advanced surgical facilities and a wide range of neurosurgical procedures.

How Are Stereotactic Surgery Devices Integrated Across Medical Practice?

In neurosurgery, stereotactic devices are used to treat conditions like brain tumors, epilepsy, and Parkinson’s disease by accurately targeting lesions or malfunctioning areas. During brain tumor treatment, these devices facilitate precise removal of abnormal tissue while minimizing damage to healthy tissue, improving patient outcomes and reducing recovery times. For epilepsy surgery, stereotactic devices help in placing electrodes deep within the brain to identify seizure foci and guide resection or ablation of the affected area. In radiation therapy, stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) use focused radiation beams to treat tumors and abnormalities with high precision, minimizing radiation exposure to surrounding tissues. Additionally, stereotactic devices are used in biopsies to collect tissue samples from hard-to-reach areas, enabling accurate diagnosis and treatment planning.

What Factors Are Driving the Growth in the Stereotactic Surgery Devices Market?

The growth in the Stereotactic Surgery Devices market is driven by several factors, including increasing demand for minimally invasive neurosurgical procedures that offer higher precision, lower risk, and faster recovery times. Advancements in imaging technologies, computer-assisted navigation, and robotics have improved the accuracy, safety, and efficiency of stereotactic surgeries, supporting broader adoption across medical applications. The focus on treating complex neurological disorders, such as brain tumors, epilepsy, and Parkinson’s disease, has further fueled demand, as stereotactic devices enable targeted interventions with minimal invasiveness. Additionally, rising healthcare investments, increased availability of specialized surgical centers, and growing awareness of advanced treatment options have contributed to market growth, encouraging the integration of stereotactic surgery devices in neurosurgical practices.

SCOPE OF STUDY:

The report analyzes the Stereotactic Surgery Devices market in terms of US$ Million by the following Product Type, and Geographic Regions/Countries:

Segments:
Product Type (Linear Accelerator (LINAC), Proton Beam Radiotherapy, Other Product Types)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Accuray Inc.
• Adeor Medical AG
• Alliance Oncology, LLC.
• Elekta AB (pub)
• Inomed Medizintechnik GmbH.
• Ion Beam Applications S.A.
• Mevion Medical Systems
• Micromar Ind. Com. Ltda.
• Modus Medical Devices Inc.
• Monteris Medical, Inc.
• Raysearch Laboratories
• Varian Medical Systems, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.